Stryker Corporation (SYK)

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Instruments Revenue (Pre FY-2026 Reporting)	-	3.18B	2.83B
Instruments Revenue (Pre FY-2026 Reporting) Growth	-	12.31%	11.84%
Endoscopy Revenue	3.81B	3.81B	3.39B
Endoscopy Revenue Growth	0.03%	12.33%	10.46%
Medical Revenue	4.16B	4.20B	3.85B
Medical Revenue Growth	-1.02%	9.14%	11.36%
Neurovascular Revenue	2.08B	1.97B	1.31B
Neurovascular Revenue Growth	5.64%	50.57%	6.61%
Neuro Cranial Revenue	-	2.49B	2.14B
Neuro Cranial Revenue Growth	-	16.34%	13.86%
MedSurg & Neurotechnology Revenue	15.34B	15.65B	13.52B
MedSurg & Neurotechnology Revenue Growth	-1.94%	15.75%	11.14%
Knees Revenue	2.69B	2.66B	2.45B
Knees Revenue Growth	1.17%	8.54%	7.66%
Hips Revenue	1.88B	1.87B	1.70B
Hips Revenue Growth	0.91%	9.45%	10.36%
Trauma and Extremities Revenue	4.04B	3.95B	3.51B
Trauma and Extremities Revenue Growth	2.28%	12.57%	11.44%
Spinal Implants Revenue	21.00M	185.00M	707.00M
Spinal Implants Revenue Growth	-88.65%	-73.83%	-0.84%
Other Orthopaedics Revenue	-	815.00M	712.00M
Other Orthopaedics Revenue Growth	-	14.47%	8.21%
Orthopaedics Revenue	9.93B	9.47B	9.08B
Orthopaedics Revenue Growth	4.84%	4.32%	8.90%
Revenue (Other)	-18.68B	-25.12B	-22.60B
Revenue (Total)	25.27B	25.12B	22.60B
Revenue (Total) Growth	0.61%	11.16%	10.23%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
United States Revenue	19.04B	19.01B	16.94B
United States Revenue Growth	0.19%	12.18%	11.05%
International Revenue	6.23B	6.11B	5.65B
International Revenue Growth	1.93%	8.10%	7.84%
Revenue (Total)	25.27B	25.12B	22.60B
Revenue (Total) Growth	0.61%	11.16%	10.23%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
MedSurg & Neurotechnology Operating Income	4.40B	4.67B	4.00B
MedSurg & Neurotechnology Operating Income Growth	-5.78%	16.68%	15.39%
Orthopaedics Operating Income	3.03B	2.82B	2.59B
Orthopaedics Operating Income Growth	7.27%	8.84%	14.39%
Operating Income (Other)	-2.44B	-2.60B	-2.91B
Operating Income (Total)	4.99B	4.89B	3.69B
Operating Income (Total) Growth	2.02%	32.53%	-5.12%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Organic Net Sales Growth	10.30%	10.20%

Data Source: Fiscal.ai Last updated: May 11, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 19, 2026

Data Sources Report a data error